Get started

OU Health

Homepage: ouhealth.com
Alternate name: Oklahoma University Health
ROR: 00a6cxf28
OpenAlex ID: I4390039271
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
2018 · Kathleen Moore, Nicoletta Colombo, et al. · New England Journal of Medicine · 2,859
PDF
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
2021 · Daniel J. Klionsky, Amal Kamal Abdel-Aziz, et al. · Autophagy · 2,608
PDF
Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response
2004 · Cord Sunderkötter, Tatjana Nikolic, et al. · The Journal of Immunology · 1,124
PDF
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
2010 · Lisa J. Moran, Marie L. Misso, et al. · Human Reproduction Update · 1,107
PDF
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
2010 · Robert A. Wild, Enrico Carmina, et al. · The Journal of Clinical Endocrinology & Metabolism · 1,012
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine
2019 · Nathan D. Donahue, Handan Acar, et al. · Advanced Drug Delivery Reviews · 945
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
2019 · Robert L. Coleman, Gini F. Fleming, et al. · New England Journal of Medicine · 913
PDF
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
2008 · Richard G. Moore, D. Scott McMeekin, et al. · Gynecologic Oncology · 875
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
2021 · Michael A. Vogelbaum, Paul D. Brown, et al. · Journal of Clinical Oncology · 833
PDF
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial
2022 · Manali Kamdar, Scott R Solomon, et al. · The Lancet · 800
PDF
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
2015 · Terry A. Jacobson, Kevin C. Maki, et al. · Journal of clinical lipidology · 782
PDF
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015 · Terry A. Jacobson, Matthew K. Ito, et al. · Journal of clinical lipidology · 773
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
2019 · Min Yuan, Li-Li Huang, et al. · Signal Transduction and Targeted Therapy · 679
PDF
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
2021 · Nancy Y Lee, Robert L Ferris, et al. · The Lancet Oncology · 654
Plasma exosome microRNAs are indicative of breast cancer
2016 · Bethany N. Hannafon, Yvonne D. Trigoso, et al. · Breast Cancer Research · 603
PDF
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis
2017 · Lenore Buckley, Gordon Guyatt, et al. · Arthritis Care & Research · 579
Elimination Pathways of Nanoparticles
2019 · Wilson Poon, Yi-Nan Zhang, et al. · ACS Nano · 575
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
2019 · Panagiotis A. Konstantinopoulos, Steven Waggoner, et al. · JAMA Oncology · 563
PDF
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
2019 · Kathleen N Moore, Angeles Alvarez Secord, et al. · The Lancet Oncology · 533
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis
2017 · Lenore Buckley, Gordon Guyatt, et al. · Arthritis & Rheumatology · 527
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
2013 · Susan R Kahn, Stan Shapiro, et al. · The Lancet · 524
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial
2022 · Paul DiSilvestro, Susana Banerjee, et al. · Journal of Clinical Oncology · 502
Advances in diagnosis and treatment of bladder cancer
2024 · Antonio Lopez-Beltran, Michael S Cookson, et al. · BMJ · 497
PDF
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
2023 · Kathleen N. Moore, Antoine Angelergues, et al. · New England Journal of Medicine · 495
PDF
Cystic Echinococcosis
2015 · Nelson Iván Agudelo Higuita, Enrico Brunetti, et al. · Journal of Clinical Microbiology · 480
Works count: 1,561
Citation count: 92,310
Year
Topic
Type